Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / U.S. PHARMA ETF
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
1,953,627
-
Shares change
-
+815,878
-
Total reported value, excl. options
-
$276,365,000
-
Value change
-
+$114,945,783
-
Put/Call ratio
-
274%
-
Number of buys
-
42
-
Number of sells
-
-38
-
Price
-
$141.42
Significant Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q4 2016
105 filings reported holding IHE - ISHARES TR - U.S. PHARMA ETF as of Q4 2016.
ISHARES TR - U.S. PHARMA ETF (IHE) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,953,627 shares
.
Largest 10 shareholders include Clal Insurance Enterprises Holdings Ltd (455,000 shares), BANK OF AMERICA CORP /DE/ (226,269 shares), MORGAN STANLEY (179,384 shares), Pinnacle Advisory Group, Inc. (134,707 shares), ARS Wealth Advisors, LLC (100,638 shares), Bogart Wealth, LLC (87,808 shares), BROWN ADVISORY INC (70,038 shares), ROYAL BANK OF CANADA (59,836 shares), SPINNAKER TRUST (59,308 shares), and GOLDMAN SACHS GROUP INC (57,382 shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.